RICHARD M. JOHNSON was named President and CEO of the Parenteral Drug Association in September 2009. Richard has been an active member of PDA, serving on the Scientific Advisory Board (co-chair); Regulatory Affairs Quality Control committee; Sterile/Aseptic Processing Interest Group (chair); Aseptic Processing committee (co-chair); GMP and Glass Defects (Chair) Task Forces.
In his more than 30 year career in the pharmaceutical and medical devices industry, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements, quality practices, and technical operations, especially in validation, sterilization, aseptic and sterile processing.
Prior positions include Vice President of Global Quality Assurance for Fort Dodge Animal Health (a division of Wyeth), Director of the Corporate Quality Center of Excellence for Abbott Laboratories, and both US and International assignments with Alcon Laboratories and Bausch & Lomb. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University. He was also the co-chair of the US Sub-TAG to ISO/TC 198 (Aseptic Processing), and has been active in the PhRMA Bar Code Committee, PQRI Aseptic Processing Working Group, ISPE and the Midwest Quality Discussion Groups since the early 1990’s.
Sessions
P1: Opening Plenary